Does TOREMIFENE Cause Endometrial hyperplasia? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Endometrial hyperplasia have been filed in association with TOREMIFENE (Fareston). This represents 4.1% of all adverse event reports for TOREMIFENE.
10
Reports of Endometrial hyperplasia with TOREMIFENE
4.1%
of all TOREMIFENE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Endometrial hyperplasia From TOREMIFENE?
Of the 10 reports, 3 (30.0%) required hospitalization.
Is Endometrial hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOREMIFENE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does TOREMIFENE Cause?
Fatigue (19)
Drug ineffective (17)
General physical health deterioration (14)
Atrial fibrillation (13)
Nausea (12)
Hepatic function abnormal (10)
Oedema peripheral (10)
Drug-induced liver injury (9)
Endometrial thickening (9)
Myelosuppression (9)
What Other Drugs Cause Endometrial hyperplasia?
LEVONORGESTREL (45)
ADALIMUMAB (35)
TAMOXIFEN (33)
MIFEPRISTONE (25)
ESTRADIOL (23)
TESTOSTERONE (13)
ANASTROZOLE (12)
BAZEDOXIFENE\ESTROGENS, CONJUGATED (10)
OCTREOTIDE (10)
AMLODIPINE (9)
Which TOREMIFENE Alternatives Have Lower Endometrial hyperplasia Risk?
TOREMIFENE vs TORIPALIMAB
TOREMIFENE vs TORSEMIDE
TOREMIFENE vs TOVIAZ
TOREMIFENE vs TOVORAFENIB
TOREMIFENE vs TOZINAMERAN